Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2006-07-03

FDA Approved: NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE — Supplemental Application (Bausch & Lomb Incoporated)

View source ↗

Summary

The FDA approved a supplemental application from Bausch & Lomb for Neomycin and Polymyxin B Sulates and Hydrocortisone, signaling an update to the product’s lab…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Neomycin and Polymyxin B Sulates and Hydrocortisone (Neomycin sulfate; polymyxin B sulfate; hydrocortisone)

Snippet

SUPPL AP for NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE (NEOMYCIN SULFATE, POLYMYXIN B SULFATE, HYDROCORTISONE)